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Introduction
43
Lyme borreliosis (LB) is the most frequent tick-borne human disease in North America and in
44
Europe. It has long been known that LB is mimicking a wider spectrum of diseases that were 45 never proven to have a spirochete etiology [1] . Involvement of new or unknown Borrelia species persisting Borrelia were considered to be noninfectious and non-cultivable [ samples from North Carolina (NC), 11 samples from Georgia (GA) and 10 from Florida (FL).
84
Five residents provided serum and plasma samples, the rest contributed either serum (8 samples) 85 or plasma (15 samples). The major symptoms observed in patients represented severe headache, 86 nausea, muscle and joint pain, numbness and tingling sensations in extremities, neck pain, back 87 pain, panic attacks, depression, dizziness, vision problems, sleep problems, and shortness of M A N U S C R I P T A C C E P T E D ImageJ, and results were statistically evaluated.
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146
Scanning electron microscopy (SEM)
147
Cultured spirochetes were pelleted at 460 × g, washed in PBS, and fixed in 2.5% glutaraldehyde 148 in PB as described above. Cells were washed three times in PB with 4% glucose, and placed on M A N U S C R I P T 
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continuous months of oral doxycycline treatment (100 mg 2 x per day) with resolution of most 180 symptoms for the following year. However, by June 2013 his previous symptoms re-emerged.
181
The female patient (sample M11p), the spouse of the male patient described above, grew 182 up in Alabama, and also lives at their residence in Georgia, USA. Over the years she experienced 
192
The patient from Florida (sample M7p) was a 58 years old female who grew up in New 
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The lack of success in spirochete cultivation from patients reported by multiple groups 15.9 ± 5.2 15.1 ± 3.5 14.5 ± 3.9 12.4 ± 3.7 13.6 ± 3.1 14.6 ± 3. 
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